3. Debt, net (Tables)

9 Months Ended

Sep. 30, 2018

Debt Disclosure [Abstract]

Schedule of debt

Description	Note	September 30, 2018			December 31, 2017
Line of credit	A	$	6,531		$	31,588
Note payable to distribution partner	B		550,000			550,000
Investor debt	C		371,507			371,507
Related party debt	D		12,659,270			10,038,037
Other notes payable	E		642,444			1,021,937
Cash draw notes	F		717,590			338,083
Convertible promissory notes	G		58,937			58,937
Total			15,006,279			12,410,089
Less: unamortized discount and debt issuance costs			(530,979	)		(484,948	)
Debt, net of unamortized discount and debt issuance costs			14,475,300			11,925,141
Less: current portion			(13,902,742	)		(11,249,083	)
Debt, long-term portion		$	572,558		$	676,058

Schedule of investor debt

September 30, 2018		December 31, 2017		Interest Rate
$	87,787	$	87,787	24%
	50,000		50,000	24%
	50,000		50,000	24%
	25,000		25,000	8%
	25,000		25,000	8%
	20,000		20,000	2%
	113,720		113,720	various
$	371,507	$	371,507

Schedule of related party debt

	September 30, 2018		December 31, 2017		Interest Rate
D1	$	4,635,865	$	4,635,865	various
D2		34,888		34,888	12%
D3		366,550		362,550	various
D4		1,205,234		1,205,234	18%
D5		6,416,733		3,799,500	6%
Total	$	12,659,270	$	10,038,037

D1 – Notes payable to Symbiote, Inc. (“Symbiote”), entered into from December 2014 to June 2016, with monthly principal and interest payable through November 2017. Symbiote is a shareholder, is the lessor of our manufacturing facility, and the provider of our payroll services. We also owe Symbiote $1,565,207 in accounts payable and accrued interest.

D2 – Note payable to our Chief Executive Officer (“CEO”), entered into in December 2014, with monthly principal and interest originally payable through December 2016. We are still continuing to accrue interest on this note payable. We also owe our CEO $939,681 in accrued compensation, accrued interest, and expenses incurred on behalf of the Company.

D3 – Notes payable to the spouse of our CEO, entered into from September 2013 to January 2018, with principal and interest payments due upon a specific event or upon demand. We also owe her $245,444 in accrued interest.

D4 – Notes payable to the consulting firm that employs our Chief Financial Officer, entered into from June 2015 to December 2017. These notes aggregated previous accounts payable and accrued interest due to the consulting firm at the time the notes were made. These notes mature at various dates through December 2019. We also owe this firm $456,673 in accrued interest.

D5 – Notes payable to the principal shareholders of Symbiote, entered into from April 2016 to September 2018, with principal and interest payments due upon a specific event or upon demand. We also owe them $264,492 in accrued interest.